-
Something wrong with this record ?
Rapidly Progressive Interstitial Lung Disease Associated with Melanoma Differentiation-Associated Gene 5 Antibody
Y. Maezawa, M. Narita, R. Tanimura, S. Hattori, H. Satoh
Language English Country Czech Republic
Document type Journal Article
Digital library NLK
Source
NLK
Directory of Open Access Journals
from 1997
Free Medical Journals
from 1997
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 2012-06-01
ROAD: Directory of Open Access Scholarly Resources
from 1997
- MeSH
- Autoantibodies MeSH
- COVID-19 * complications MeSH
- Dermatomyositis * complications MeSH
- Lung Diseases, Interstitial * complications MeSH
- Humans MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Anti-melanoma differentiation-associated gene-5 (MDA-5) antibody is an autoantibody found in patients with dermatomyositis. These antibody-positive patients are clinically characterized by complications of rapidly progressive interstitial pneumonia resistant to treatment and with poor prognosis. We describe herein a patient with MDA-5 antibody-positive interstitial lung disease, which progressed rapidly to death after a period of slow progress. Recently, attention has been paid to the similarities in clinical courses and CT images between MDA-5 antibody-positive interstitial lung disease and coronavirus disease 2019 (COVID-19)-associated pneumonia. Patients with MDA-5 antibody do not always have diffuse and evenly distributed bilateral opacities at the time of first presentation. This patient had significant laterality of such opacities. It should be considered that MDA-5 antibody-positive patients with such laterality in opacities might progress rapidly. Chest physicians, dermatologists, and dermatologists need to be aware of the characteristics of the disease for optimal treatment choices.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22016355
- 003
- CZ-PrNML
- 005
- 20221014133146.0
- 007
- ta
- 008
- 220714s2022 xr a f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/18059694.2022.15 $2 doi
- 035 __
- $a (PubMed)35793508
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Maezawa, Yosuke $u Division of General Medicine, University of Tsukuba, Mito Medical Center-Mito Kyodo General Hospital, Mito, Ibaraki, Japan
- 245 10
- $a Rapidly Progressive Interstitial Lung Disease Associated with Melanoma Differentiation-Associated Gene 5 Antibody / $c Y. Maezawa, M. Narita, R. Tanimura, S. Hattori, H. Satoh
- 520 9_
- $a Anti-melanoma differentiation-associated gene-5 (MDA-5) antibody is an autoantibody found in patients with dermatomyositis. These antibody-positive patients are clinically characterized by complications of rapidly progressive interstitial pneumonia resistant to treatment and with poor prognosis. We describe herein a patient with MDA-5 antibody-positive interstitial lung disease, which progressed rapidly to death after a period of slow progress. Recently, attention has been paid to the similarities in clinical courses and CT images between MDA-5 antibody-positive interstitial lung disease and coronavirus disease 2019 (COVID-19)-associated pneumonia. Patients with MDA-5 antibody do not always have diffuse and evenly distributed bilateral opacities at the time of first presentation. This patient had significant laterality of such opacities. It should be considered that MDA-5 antibody-positive patients with such laterality in opacities might progress rapidly. Chest physicians, dermatologists, and dermatologists need to be aware of the characteristics of the disease for optimal treatment choices.
- 650 _2
- $a autoprotilátky $7 D001323
- 650 12
- $a COVID-19 $x komplikace $7 D000086382
- 650 12
- $a dermatomyozitida $x komplikace $7 D003882
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a intersticiální plicní nemoci $x komplikace $7 D017563
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Narita, Mami $u Division of General Medicine, University of Tsukuba, Mito Medical Center-Mito Kyodo General Hospital, Mito, Ibaraki, Japan
- 700 1_
- $a Tanimura, Riho $u Division of General Medicine, University of Tsukuba, Mito Medical Center-Mito Kyodo General Hospital, Mito, Ibaraki, Japan
- 700 1_
- $a Hattori, Sou $u Division of General Medicine, University of Tsukuba, Mito Medical Center-Mito Kyodo General Hospital, Mito, Ibaraki, Japan
- 700 1_
- $a Satoh, Hiroaki $u Division of Respiratory Medicine, University of Tsukuba, Mito Medical Center-Mito Kyodo General Hospital, Mito, Ibaraki, Japan. hirosato@md.tsukuba.ac.jp
- 773 0_
- $w MED00010947 $t Acta Medica $x 1805-9694 $g Roč. 65, č. 1 (2022), s. 37-40
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35793508 $y Pubmed
- 910 __
- $a ABA008 $b A 3077 $c 1072 $y p $z 0
- 990 __
- $a 20220714 $b ABA008
- 991 __
- $a 20221014133139 $b ABA008
- 999 __
- $a ok $b bmc $g 1848308 $s 1167597
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 65 $c 1 $d 37-40 $e - $i 1805-9694 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
- LZP __
- $b NLK138 $a Pubmed-20220714